Publication Name	World Journal of Gastroenterology
Manuscript ID	34820
Country	Japan

Received	2017-05-27 01:00
Peer-Review Started	2017-05-28 14:15
To Make the First Decision	2017-06-22 00:59
Return for Revision	2017-06-23 09:22
Revised	2017-07-04 14:22
Second Decision	2017-07-21 08:55
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-07-24 02:32
Articles in Press	2017-07-24 02:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-08-11 12:08
Publish the Manuscript Online	2017-08-19 11:33

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
Manuscript Source	Invited Manuscript
All Author List	Tatsuo Kanda and Mitsuhiko Moriyama
ORCID	Author(s) ORCID Number Tatsuo Kanda http://orcid.org/0000-0002-9565-4669 Mitsuhiko Moriyama http://orcid.org/0000-0002-4617-508X
Funding Agency and Grant Number
Corresponding Author	Tatsuo Kanda, MD, PhD, Associate Professor, Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi kamimachi, Itabashi-ku, Tokyo 173-8610, Japan. kandat-cib@umin.ac.jp
Key Words	Cholesterol; Hepatitis C virus; Interferon-free; Lipid metabolism
Core Tip	Eradication of hepatitis C virus (HCV) de­creases the rate of complications, including liver-related and liver-unrelated death, and improves patient quality of life. Individuals infected with HCV have an increased risk of cardiovascular diseases and intracerebral hemorrhage, which are both associated with lipid metabolism. HCV infection causes abnormal host lipid metabolism. Treatment with interferon-based and interferon-free regimens has an impact on the eradication of HCV, as well as lipid abnormalities, during treatment and after treatment. Further observations are needed to determine the long-term effects on lipid metabolism caused by HCV and by eradication of the virus.
Publish Date	2017-08-19 11:33
Citation	Kanda T, Moriyama M. Direct-acting antiviral agents against hepatitis C virus and lipid metabolism. World J Gastroenterol 2017; 23(31): 5645-5649
URL	http://www.wjgnet.com/1007-9327/full/v23/i31/5645.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i31.5645

Full Article (PDF)	WJG-23-5645.pdf
Full Article (Word)	WJG-23-5645.doc
Manuscript File	34820-Review.docx
Answering Reviewers	34820-Answering reviewers.pdf
Audio Core Tip	34820-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	34820-Conflict-of-interest statement.pdf
Copyright License Agreement	34820-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	34820-Language certificate.pdf
Peer-review Report	34820-Peer-review(s).pdf
Scientific Misconduct Check	34820-Scientific misconduct check.pdf
Scientific Editor Work List	34820-Scientific editor work list.pdf